Researchers conducted a metaumbrella review of 34 systematic reviews and 70 studies, uncovering a significant link between COVID-19 severity and increased stroke risk. The review emphasizes the need for further investigation into underlying mechanisms and potential biases.
FDA approves schizophrenia drug that could alter how disorder is treated
For decades, doctors caring for people with schizophrenia have relied on mood-regulating drugs that target the brain chemical dopamine. On Thursday, the Food and Drug
September 26, 2024